{
    "root": "36229f70-aa6e-b112-e063-6394a90a5b49",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Carvedilol",
    "value": "20250527",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "68401960MK"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4"
        },
        {
            "name": "CARVEDILOL",
            "code": "0K47UL67F2"
        }
    ],
    "indications": "carvedilol alpha-/beta-adrenergic blocking agent indicated treatment : mild severe chronic heart failure ( 1.1 ) left ventricular dysfunction following myocardial infarction clinically stable patients ( 1.2 ) hypertension ( 1.3 )",
    "contraindications": "carvedilol tablets taken food slow rate absorption reduce incidence orthostatic effects .",
    "warningsAndPrecautions": "carvedilol tablets usp , 6.25 mg white off-white , oval shaped , film-coated tablets debossed ‘ e ’ one side ‘ 02 ’ side . ndc : 70518-0123-00 ndc : 70518-0123-01 ndc : 70518-0123-02 packaging : 30 1 blister pack packaging : 180 1 bottle plastic packaging : 90 1 bottle plastic store 20 25°c ( 68 77°f ) [ usp controlled room temperature ] . protect moisture . dispense tight , light-resistant container . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "carvedilol tablets contraindicated following conditions : bronchial asthma related bronchospastic conditions . deaths status asthmaticus reported following single doses carvedilol tablets . second- third-degree av block . sick sinus syndrome . severe bradycardia ( unless permanent pacemaker place ) . patients cardiogenic shock decompensated heart failure requiring intravenous inotropic therapy . patients first weaned intravenous therapy initiating carvedilol tablets . patients severe hepatic impairment . patients history serious hypersensitivity reaction ( e.g . , stevens-johnson syndrome , anaphylactic reaction , angioedema ) component medication medications containing carvedilol .",
    "indications_original": "Carvedilol is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure ( 1.1 ) left ventricular dysfunction following myocardial infarction in clinically stable patients (1.2) hypertension (1.3)",
    "contraindications_original": "Carvedilol tablets should be taken with food to slow the rate of absorption and reduce the incidence of orthostatic effects.",
    "warningsAndPrecautions_original": "Carvedilol Tablets USP, 6.25 mg are white to off-white, oval shaped, film-coated tablets debossed with ‘E’ on one side and ‘02’ on the other side.\n                  NDC: 70518-0123-00\n                  NDC: 70518-0123-01\n                  NDC: 70518-0123-02\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 180 in 1 BOTTLE PLASTIC\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  \n                  Store at 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight, light-resistant container.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Carvedilol tablets are contraindicated in the following conditions:\n                  \n                  \n                     Bronchial asthma or related bronchospastic conditions. Deaths from status asthmaticus have been reported following single doses of carvedilol tablets.\n                     Second- or third-degree AV block.\n                     Sick sinus syndrome.\n                     Severe bradycardia (unless a permanent pacemaker is in place).\n                     Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy. Such patients should first be weaned from intravenous therapy before initiating carvedilol tablets.\n                     Patients with severe hepatic impairment.\n                     Patients with a history of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol."
}